Top

Published in:

01-12-2010 | Letter to the Editor

Readability of Patient Information Regarding Breast Cancer Prevention from the Web site of the National Cancer Institute

Author: Ian C. Hoppe

Published in: Journal of Cancer Education | Issue 4/2010

Abstract

The increasing use of the Internet for gathering information regarding preventative health measures creates a unique dilemma. Access to the Internet is almost universal in the USA. Web sites presenting health information regarding breast cancer must create information that is understandable to the general public, meaning a reading level of around seventh grade. Text was obtained from the National Cancer Institute's Web site, and an examination of the text's grade level was performed. The text was written at between a 10th and 12th grade level. This indicates that information regarding breast cancer prevention obtained from the National Cancer Institute's web site is written at far too high of a level.

Lawrence S, Giles CL (1999) Accessibility of information on the Web. Nature 400(6740):107–109CrossRefPubMed

Horrigan J RL (2006) The Internet's growing role in life's major moments. http://www.pewinternet.org/PPF/r/181/report_display.asp. Accessed 15 November 2009

National Institutes of Health (2007) How to write easy to read health materials. http://www.nlm.nih.gov/medlineplus/etr.html. Accessed 15 November 2009

National Cancer Institute (2003) Clear & simple: developing effective print materials for low-literate readers. http://www.cancer.gov/cancerinformation/clearandsimple. Accessed 15 November 2009

DuBay W (2004) The principles of readability. www.impact-information.com/impactinfo/readability02.pdf. Accessed 15 November 2009

McLaughlin GH (1969) SMOG grading—a new readability formula. J Read 12(8):639–646

Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd JC (2000) Anticoagulant patient information material is written at high readability levels. Stroke 31(12):2966–2970PubMed

Vallance JK, Taylor LM, Lavallee C (2008) Suitability and readability assessment of educational print resources related to physical activity: implications and recommendations for practice. Patient Educ Couns 72(2):342–349CrossRefPubMed

Hoffmann T, McKenna K (2006) Analysis of stroke patients' and carers' reading ability and the content and design of written materials: recommendations for improving written stroke information. Patient Educ Couns 60(3):286–293CrossRefPubMed

10.

Flesch R (1948) A new readability yardstick. J Appl Psychol 32(3):221–233CrossRefPubMed

11.

Grossman SA, Piantadosi S, Covahey C (1994) Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol 12(10):2211–2215PubMed

12.

D'Alessandro DM, Kingsley P, Johnson-West J (2001) The readability of pediatric patient education materials on the World Wide Web. Arch Pediatr Adolesc Med 155(7):807–812PubMed

13.

Croft DR, Peterson MW (2002) An evaluation of the quality and contents of asthma education on the World Wide Web. Chest 121(4):1301–1307CrossRefPubMed

14.

Stinson JN, Tucker L, Huber A et al (2009) Surfing for juvenile idiopathic arthritis: perspectives on quality and content of information on the Internet. J Rheumatol 36(8):1755–1762CrossRefPubMed

15.

Badarudeen S, Sabharwal S (2008) Readability of patient education materials from the American Academy of Orthopaedic Surgeons and Pediatric Orthopaedic Society of North America Web sites. J Bone Jt Surg Am 90(1):199–204CrossRef

16.

Montazeri A, Sajadian A (2004) Do women read poster displays on breast cancer in waiting rooms? J Public Health (Oxf) 26(4):355–358CrossRef

Title: Readability of Patient Information Regarding Breast Cancer Prevention from the Web site of the National Cancer Institute
Author: Ian C. Hoppe
Publication date: 01-12-2010
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 4/2010
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-010-0101-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Knowledge and Accuracy of Perceived Personal Risk in Underserved Women Who are at Increased Risk of Breast Cancer

An Analysis of Educational and Learning Needs of Cancer Patients and Unrelated Family Caregivers

Help Me in My Confusion: Should We Think More About Mammography and Colonoscopy as “Preference Sensitive Care’?

Prevalence of Cancer Visits by Physician Specialty, 1997–2006

Evaluation of a Survivorship Educational Program for Adolescent and Young Adult Survivors of Childhood Cancer

A Survey of Head and Neck Cancer Curriculum in United States Speech Language Pathology Masters Programs

Keynote webinar | Spotlight on antibody–drug conjugates in cancer